Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Manu M. Sebastian Image

      Manu M. Sebastian, DVM, PhD

      Department of Veterinary Medicine and Surgery, Division of Division of Discovery Science

      Present Title & Affiliation

      Primary Appointment

      Professor, Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

      Faculty Member, Livestrong Cancer Institute, UT Austin, Austin, TX

      Faculty member, Dell Medical School, Austin, TX

      Education & Training

      Degree-Granting Education

      2004University of Kentucky, Lexington, Kentucky, US, Veterinary Pathology, PhD
      1993College of Veterinary Science, Kerala , India, Kerala, IN, Veterinary Pathology, MS
      1990College of Veterinary Science, Kerala, India, Kerala, IN, Veterinary Medicine, DVM

      Postgraduate Training

      1999-2002Residency in Veterinary Pathology, University of Kentucky, Lexington, Kentucky

      Licenses & Certifications

      2019Fellow, International Academy of Toxicologic Pathology
      2011Diplomate, American College of Laboratory Animal Medicine
      2007Diplomate, American Board of Toxicology
      2006Diplomate, American College of Veterinary Pathology

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023

      Associate Professor, Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023

      Assistant Professor, College of Veterinary Medicine, Cornell University, Ithaca, NY, 2018 - 2021

      Associate Professor, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2016 - 2021

      Adjunct Assistant Professor, College of Veterinary Medicine, Cornell University, Ithaca, NY, 2008 - 2016

      Assistant Professor of Clinical Pathology, Dept of Pathology, College of Physicians & Surgeons, Columbia University, New York, NY, 2007 - 2010

      Assistant Professor of Pathology, Chief of University Toxicology Testing, University of Georgia, Athens, GA, 2004 - 2007

      Assistant Professor, Pathology, College of Veterinary Science Trichur, Kerala, 1994 - 1999

      Other Professional Positions

      Member, Advisory Board, AuraVax, Houston, Texas, 2021 - Present

      Advisory Board, Clarapath, Hawthorne, NY, 2021 - Present

      Member, Advisory Board, PathPresenter, NY, 2020 - Present

      Advisor, UT Austin, Texas Health Catalyst, Austin, 2019 - Present

      Member, MDACC Faculty Senate, Houston, TX, 2017 - 2021

      Director, Research Histology Pathology Imaging Laboratory, The University of Texas MD Anderson Cancer Center, Smithville, Texas, 2016 - 2021

      Associate Director, Non Clinical Development, Soligenix, Princeton, NJ, 2015 - 2016

      Ad Hoc Member/Site Visitor, AAALAC International, Frederick, MD, 2012 - 2018

      Pathology Section Supervisor, Experimur, Chicago, IL, 2011 - 2014

      Member, University Of Texas Graduate School of Biomedical Sciences, Houston, TX, 2010 - Present

      Member, Medical Advisory Board, Women at Risk (Non-Profit organization for breast cancer research and prevention), New York, NY, 2009 - 2010

      Member, Control Substance Working Group, Columbia University, New York, NY, 2008 - 2010

      Member, Stem Cell Consortium, Columbia University, New York, NY, 2008 - 2010

      Member, Institutional Health & Safety Council, Columbia University, New York, NY, 2008 - 2009

      Chief of Comparative Pathology, Columbia University, New York, NY, 2007 - 2010

      Diagnostic Pathologist, University of Kentucky, Lexington, KY, 2002 - 2004

      Extramural Institutional Committee Activities

      Member, MDACC Institutional Digital Pathology Working Group, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, MDACC Institutional Animal Care & Use Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2021

      Honors & Awards

      2009Best Publication Award in "Veterinary Pathology", CL Davis Foundation
      2005Young Investigator Award, American College of Veterinary Pathology

      Professional Memberships

      American College of Laboratory Animal Medicine

      2024 - Present

      Society of Toxicological Pathologists

      2023 - Present

      Digital Pathology Association

      2019 - Present

      Digital Pathology Association

      2019 - Present

      Association for Advancement of Medical Instrumentation

      2019 - Present

      Society of Toxicological Pathologists

      2019 - 2021

      Society of Toxicological Pathologists

      2019 - 2021

      American Association of Cancer Research

      2018 - Present

      Society of Toxicological Pathologists, Subcommittee on Digital Pathology

      2018 - 2020

      Society of Toxicological Pathologists, Lone Star Chapter

      2017 - Present

      Society of Toxicology, Lone Star Chapter

      2017 - Present

      American College of Laboratory Animal Medicine, Career Outreach Committee

      2016 - 2018

      American College of Veterinary Pathologists

      2014 - Present

      American College of Veterinary Pathologists

      2012 - Present

      American College of Laboratory Animal Medicine

      2011 - Present

      Society of Toxicology

      2007 - Present

      American Board of Toxicology

      2007 - Present

      Society of Toxicological Pathologists: Career Outreach Committee

      2007 - 2010

      American College of Veterinary Pathologists

      2006 - Present

      Society of Toxicological Pathologists

      2006 - Present

      American College of Veterinary Pathologists

      2006 - Present

      Society of Toxicology, Toxicology & Experimental Pathology Committee

      2005 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2017. Role of Veterinarians in Translational Medicine. Conference. Role of Veterinarians in Translational Medicine. Incheon.
      2. 2003. Induction of Mare Reproductive Loss Syndrome with irradiated eastern tent caterpillars to assess whether the primary pathogen in MRLS is a toxic molecule or a microorganism. Conference. Induction of Mare Reproductive Loss Syndrome with irradiated eastern tent caterpillars to assess whether the primary pathogen in MRLS is a toxic molecule or a microorganism. Lexington, KY, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2027 - 2032
      Title:Metabolic gating of tertiary lymphoid maturation and immune restoration in MASH-associated hepatocellular carcinoma
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:FP00030024
      Date: 2025 - 2028
      Title:Preclinical Validation of Novel Combination Therapeutic Strategies Targeting KRAS and BRAF Mutated Colorectal Cancer for Near-Term Clinical Examination
      Funding Source:Baylor College of Medicine
      Role:Collaborator
      ID:FP00027696
      Date: 2025 - 2028
      Title:Preclinical Validation of Novel Combination Therapeutic Strategies Targeting KRAS and BRAF Mutated Colorectal Cancer for Near Term Clinical Examination
      Funding Source:US Department of Defense
      Role:Collaborator
      ID:FP00024138
      Date: 2025 - 2027
      Title:Characterization of a novel Foxl2- dependent ovarian granulosa cell tumor mouse model
      Funding Source:NATIONAL INSTITUTES OF HEALTH
      Role:Collaborator
      Date: 2025 - 2028
      Title:Novel Combination Therapeutic Strategies for KRAS and BRAF Mutated Colorectal Cancer
      Funding Source:CPRIT
      Role:Collaborator
      Date: 2025 - 2026
      Title:Novel combination strategies targeting vulnerabilities of KRAS and BRAF mutated colorectal cancer
      Funding Source:HOPE FOUNDATION
      Role:Collaborator
      Date: 2024 - 2027
      Title:Identification and Validation of Novel Combination Therapeutic Strategies for KRAS and BRAF Mutated Colorectal Cancer
      Funding Source:Department of Defense (DOD)
      Role:Collaborator
      Date: 2024 - 2025
      Title:Genetically modified role of MUC13 in Pancreatic Cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:Targeting PPAR-d alteration and immune suppression for gastric cancer prevention and therapy
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:Genetically define the role of MUC13 in pancreatic carcinogenesis
      Funding Source:NIH
      Role:PI
      Date: 2023 - 2028
      Title:Molecular Dissection of host–environment interaction in gastric tumorigenesis
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      Date: 2022 - 2027
      Title:MIPS Center: Targeted Interception Program to Develop Molecular and Immunologic Prevention Strategies
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2025
      Title:Development of PARG Inhibitors to Treat PARPi-resistant Breast Cancer
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:Co-I
      Date: 2021 - 2026
      Title:Modulation of Neuroimmune Pathways by WWOX: Implications for Complex Brain Disorders
      Funding Source:NIH/NIMH
      Role:Collaborator
      Date: 2021 - 2026
      Title:Molecular Understanding and Targeting of Determinant Factors in Gastric Tumorigenesis
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1R01CA236905-01A1
      Date: 2021 - 2026
      Title:Pharmacological Modulation of Poly(ADP-ribose) Metabolism
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01
      Date: 2021 - 2026
      Title:Investigation of toxins and phage in Acinetobacter baumannii pathogenesis
      Funding Source:UT-Austin/NIH
      Role:Co-I
      Date: 2021 - 2026
      Title:PPAR-d regulation of gastric progenitor cell sternness and tumorigenesis
      Funding Source:NIH
      Role:Co-I
      ID:R01
      Date: 2020 - 2025
      Title:Bis-allylic deuterated arachidonic acid (D-ARA) therapeutic for Covid-19 lung injury
      Funding Source:UT-Austin/NIH/NIAID
      Role:Co-I
      ID:GRANT13186003
      Date: 2020 - 2021
      Title:Hamamtsu NanoZoomer S60 Brightfield + Fluorescence Slide Scanning system
      Funding Source:NIH/NIGMS
      Role:PI
      ID:GRANT12863610
      Date: 2019 - 2022
      Title:NCI Preclinical PREVENT Cancer Program
      Funding Source:NIH/NCI
      Role:Co-I
      ID:TORFP 2019 E-05
      Date: 2019 - 2023
      Title:Genetic and Molecular Definition of Histone Modifying Enzyme Functions
      Funding Source:NIH/NIGMS
      Role:Co-I
      ID:GM131678-01
      Date: 2019 - 2024
      Title:DNA Polymerase Beta and Mechanisms of Carcinogenesis
      Funding Source:UT-Austin / NIH
      Role:Co-I
      ID:R01 Subcontract
      Date: 2019 - 2021
      Title:Defective Base Excision Repair and Mechanisms of Infection Related Cancer
      Funding Source:UT-Austin / NIH
      Role:Co-I
      ID:R21 Subcontract
      Date: 2019 - 2021
      Title:Defective Base Excision Repair and Mechanisms of Infection Related Cancer
      Funding Source:UT-Austin / NIH
      Role:Co-I
      ID:R21
      Date: 2019 - 2020
      Title:Hamamtsu NanoZoomer S60 Brightfield + Fluorescence Slide Scanning system
      Funding Source:NIH
      Role:PI
      ID:S10 OD027030-01
      Date: 2018 - 2023
      Title:The impact of nicotine product switching on use, toxicant exposure, and biomarkers of risk on smoking-related chronic medical illness
      Funding Source:NIH/FDA
      Role:Co-I
      ID:U54
      Date: 2018 - 2023
      Title:PPAR-d Regulation of Gastric Progenitor Cell Stemness and Tumorigenesis
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01CA222106
      Date: 2018 - 2021
      Title:Defining the Effects of USP22 Over Expression in Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP180083
      Date: 2017 - 2019
      Title:Targeted casein kinase 1δ (CK1δ) inhibition as a breast cancer prevention strategy
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:TORFP 2017-E05
      Date: 2013 - 2016
      Title:Development of Medical Countermeasures to Mitigate or Treat the Gastrointestinal Acute Radiation Syndrome after a Nuclear or Radiation Incident
      Funding Source:NIH/NIAID
      Role:Chief Preclinical Investigator/Pathologist
      ID:HHSN272201300030C
      Date: 2013 - 2021
      Title:Cancer Center Support Grant (CCSG)-Core Grant
      Funding Source:NIH/NCI
      Role:Co-I
      ID:P30 CA16672
      Date: 2008 - 2011
      Title:Rad9-Based Mouse Model of Prostate Cancer
      Funding Source:NIH
      Role:Co-PI
      Title:Hybernia Safety Catheter for Neuroprotection via Selective Hypothermia
      Funding Source:NIH
      Role:Co-PI

      Selected Publications

      Peer-Reviewed Articles

      1. Chauhan, C, Parwani, AV, Schumacher, V, Sebastian, MM, Bui, MM, Lin, PC, Blakely, S, Fathima, S, Gibbs, J, Horchner, U, Lujan, G, Osamura, RY, Pantanowitz, L, Samboy, J, Zioga, C, Herrmann, MD, Yeh, J, Oen, H, Dash, RC, Lennerz, JK, Schmid, J. The critical role of standards for AI in digital pathology. Journal of Pathology Informatics 21, 2026. e-Pub 2026. PMID: 41809691.
      2. Glazer SE, Sutton MN, Yang P, Pisaneschi F, Sebastian M, Gammon ST, Piwnica-Worms D. Anti-cancer immune priming with beta-radioligand therapy using a novel high affinity antibody selectively targeting the 4Ig-Isoform of B7-H3. Theranostics 16(10):5370-5392, 2026. e-Pub 2026. PMID: 41993624.
      3. Ahmad M, Alvi SS, Ahsan H, Perez C, Massey A, Kashyap VK, Chauhan N, Anning E, Tripathi MK, Kim DJ, Sahoo N, Oraby T, Yallapu MM, Khan MM, Sebastian MM, Chauhan SC, Hafeez BB. Ubiquitination of oncogenic mutant p53 via attenuation of ribosome biogenesis machinery effectively inhibits pancreatic tumor growth. Mol Cancer Ther 25(2):257-271, 2025. e-Pub 2025. PMID: 41053975.
      4. Deng S, Hussain T, Bartelli TF, Sebastian MM, Zarghooni M, Velasco WV, Somerville B, Phan L, Savage MI, Song Y, Clifford JL, Kadara H, McAllister F, Brown PH, Moghaddam SJ, Aldaz CM. Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung Cancer. Mol Cancer Ther 25(2):283-294, 2025. e-Pub 2025. PMID: 41024580.
      5. Ramaiah, L, Arndt, T, Thomas, G, Shirai, N, Sebastian, MM, Sims, C, Bailey, S. Toxicologic Pathology Forum* Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies. Toxicologic pathology 53(6):571-581, 2025. e-Pub 2025. PMID: 40448609.
      6. Kotagiri, S, Wang, Y, Han, Y, Liang, X, Blazanin, N, Mazhar, H, Sebastian, MM, Nguyen, PK, Jiang, Y, Lissanu, Y. Discovery of Novel, Potent, and Orally Bioavailable SMARCA2 Proteolysis-Targeting Chimeras with Synergistic Antitumor Activity in Combination with Kirsten Rat Sarcoma Viral Oncogene Homologue G12C Inhibitors. Journal of Medicinal Chemistry 68(9):9202-9219, 2025. e-Pub 2025. PMID: 40280558.
      7. Wible DJ, Li WJ, Liu X, Sebastian MM, Tang DG, Bratton SB. Loss of ATG5 expression in a subset of human prostate cancers promotes tumor growth through accumulation of p62. bioRxiv, 2025. e-Pub 2025. PMID: 40625641.
      8. Li J, Welte T, Calzoncinth K, Vuttaradhi VK, Brodsky AL, Wong KK, Sebastian MM, Lawson B, Kingsley CV, Hillman RT. An inducible FOXL2-dependent mouse model of ovarian adult type granulosa cell tumor. Gynecol Oncol 194:125-130, 2025. e-Pub 2025. PMID: 40221170.
      9. Leekha A, Saeedi A, Kumar M, Sefat KMSR, Martinez-Paniagua M, Meng H, Fathi M, Kulkarni R, Reichel K, Biswas S, Tsitoura D, Liu X, Cooper LJN, Sands CM, Das VE, Sebastian M, Hurst BL, Varadarajan N. An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models. Nat Commun 15(1):6053, 2024. e-Pub 2024. PMID: 39025863.
      10. Wright, T, Wang, Y, Stratton, SA, Sebastian, MM, Liu, B, Johnson, DG, Bedford, MT. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma. Biochemical Journal 148(22):1805-1816, 2023. e-Pub 2023. PMID: 37905668.
      11. Ghosh S, Fan F, Powell RT, Roszik J, Park YS, Stephan C, Sebastian M, Tan L, Sorokin AV, Lorenzi PL, Kopetz S, Ellis LM, Bhattacharya R. Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer. Mol Cancer Ther 22(8):962-975, 2023. e-Pub 2023. PMID: 37310170.
      12. Liu Y, Ahumada AL, Bayraktar E, Schwartz P, Chowdhury M, Shi S, Sebastian M, Khant H, de Val N, Bayram NN, Zhang G, Vu TC, Jie Z, Jennings NB, Rodriguez-Aguayo C, Swain J, Stur E, Mangala LS, Wu Y, Nagaraju S, Ermias B, Li C, Lopez-Berestein G, Braam J, Sood AK. Enhancing oral delivery of plant-derived vesicles for colitis. J Control Release 357:472-483, 2023. e-Pub 2023. PMID: 37031740.
      13. Fontes, F, Rocha, S, Sánchez, R, Pessina, P, Sebastian, MM, Benavides, FJ, Breijo, M. Detection of high antibodies titers against rat leukemia virus in an outbreak of reproductive disorders and lymphomas in Wistar rats. Laboratory Animals 56(5):437-445, 2022. e-Pub 2022. PMID: 35360996.
      14. Zhao S, Goewey Ruiz JA, Sebastian M, Kidane D. Defective DNA polymerase beta invoke a cytosolic DNA mediated inflammatory response. Front Immunol 13:1039009, 2022. e-Pub 2022. PMID: 36624848.
      15. Wurster JI, Peterson RL, Brown CE, Penumutchu S, Guzior DV, Neugebauer K, Sano WH, Sebastian M, Quinn RA, Belenky P. Streptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosis. Cell Rep 37(11):110113, 2021. e-Pub 2021. PMID: 34910917.
      16. Yang F, Chen J, Liu B, Gao G, Sebastian M, Jeter C, Shen J, Person MD, Bedford MT. SPINDOC binds PARP1 to facilitate PARylation. Nat Commun 12(1):6362, 2021. e-Pub 2021. PMID: 34737271.
      17. Shah VV, Duncan AD, Jiang S, Stratton SA, Allton KL, Yam C, Jain A, Krause PM, Lu Y, Cai S, Tu Y, Zhou X, Zhang X, Jiang Y, Carroll CL, Kang Z, Liu B, Shen J, Gagea M, Sebastian M, Huo L, Gilcrease M, Powell RT, Guo L, Stephan C, Davies PJ, Parker-Thornburg J, Lozano G, Behringer RR, Piwnica-Worms H, Chang JT, Moulder SL, Barton MC. Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer. Nat Commun 12(1):5389, 2021. e-Pub 2021. PMID: 34508101.
      18. Kos, Z, Roblin, E, Kim, RS, Michiels, S, Gallas, BD, Chen, W, Van De Vijver, K, Goel, S, Adams, S, Demaria, S, Viale, G, Nielsen, TO, Badve, S, Symmans, WF, Sotiriou, C, Rimm, DL, Hewitt, SM, Denkert, C, Loibl, S, Luen, SJ, Bartlett, JM, Savas, P, Pruneri, G, Dillon, D, Cheang, M, Tutt, A, Hall, JA, Kok, M, Horlings, HM, Madabhushi, A, van der Laak, J, Ciompi, F, Lænkholm, AV, Bellolio, E, Gruosso, T, Fox, SB, Araya O, JC, Floris, G, Hudeček, J, Voorwerk, L, Beck, AH, Kerner, J, Larsimont, D, Declercq, S, Van Den Eynden, GG, Pusztai, L, Yang, W, Yuan, Y, Lazar, A, Sebastian, MM. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. npj Breast Cancer 6(1), 2020. e-Pub 2020. PMID: 32411819.
      19. Davis JS, Kanikarla-Marie P, Gagea M, Yu PL, Fang D, Sebastian M, Yang P, Hawk E, Dashwood R, Lichtenberger LM, Menter D, Kopetz S. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development. BMC Cancer 20(1):871, 2020. e-Pub 2020. PMID: 32912193.
      20. Turner OC, Aeffner F, Bangari DS, High W, Knight B, Forest T, Cossic B, Himmel LE, Rudmann DG, Bawa B, Muthuswamy A, Aina OH, Edmondson EF, Saravanan C, Brown DL, Sing T, Sebastian M. Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology. Toxicol Pathol 48(2):192623319881401, 2020. e-Pub 2020. PMID: 31645203.
      21. Zhao S, Klattenhoff AW, Thakur M, Sebastian M, Kidane D. Mutation in DNA Polymerase Beta Causes Spontaneous Chromosomal Instability and Inflammation-Associated Carcinogenesis in Mice. Cancers (Basel) 11(8), 2019. e-Pub 2019. PMID: 31412651.
      22. Zuo X, Deguchi Y, Xu W, Liu Y, Li HS, Wei D, Tian R, Chen W, Xu M, Yang Y, Gao S, Jaoude JC, Liu F, Chrieki SP, Moussalli MJ, Gagea M, Sebastian M, Zheng X, Tan D, Broaddus R, Wang J, Ajami NJ, Swennes AG, Watowich SS, Shureiqi I. PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice. Gastroenterology 157(1):163-178, 2019. e-Pub 2019. PMID: 30885780.
      23. Bao J, Di Lorenzo A, Lin K, Lu Y, Zhong Y, Sebastian M, Muller WJ, Yang Y, Bedford MT. Mouse models of overexpression reveal distinct oncogenic roles for different type I protein arginine methyltransferases. Cancer Res 79(1):21-32, 2019. e-Pub 2019. PMID: 30352814.
      24. McBride KM, Kil H, Mu Y, Plummer JB, Lee J, Zelazowski MJ, Sebastian M, Abba MC, Aldaz CM. Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies. Front Oncol 9(JUN):517, 2019. e-Pub 2019. PMID: 31275852.
      25. Bartkowiak T, Jaiswal AR, Ager CR, Chin R, Chen CH, Budhani P, Ai M, Reilley MJ, Sebastian M, Hong DS, Curran MA. Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway. Clin Cancer Res 24(5):1138-1151, 2018. e-Pub 2018. PMID: 29301830.
      26. Bujold K, Hauer-Jensen M, Donini O, Rumage A, Hartman D, Hendrickson HP, Stamatopoulos J, Naraghi H, Pouliot M, Ascah A, Sebastian M, Pugsley MK, Wong K, Authier S. Citrulline as a biomarker for gastrointestinal-acute radiation syndrome: Species differences and experimental condition effects. Radiat Res 186(1):71-8, 2016. e-Pub 2016.
      27. Lifante JC, Milone L, Korner J, Kopsombut G, Sebastian M, Inabnet WB. Sleeve gastrectomy improves glucose homeostasis in Zucker diabetic fatty rats. Obes Surg 22(7):1110-6, 2012. e-Pub 2012. PMID: 22555866.
      28. Kopsombut G, Shoulson R, Milone L, Korner J, Lifante JC, Sebastian M, Inabnet WB. Partial small bowel resection with sleeve gastrectomy increases adiponectin levels and improves glucose homeostasis in obese rodents with type 2 diabetes. World J Surg 36(6):1432-8, 2012. e-Pub 2012. PMID: 22362044.
      29. Sonabend AM, Stuart RM, Yun J, Yanagihara T, Mohajed H, Dashnaw S, Bruce SS, Brown T, Romanov A, Sebastian M, Arias-Mendoza F, Bagiella E, Canoll P, Bruce JN. Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol 13(8):886-93, 2011. e-Pub 2011. PMID: 21750007.
      30. Bernard, WV, Sebastian, MM, Hemming, B. Salmonella Antimicrobial Activity of Selected Strains of Enterolactobacillus Species Isolated from the Gastrointestinal Tract of the Horse. Journal of Equine Veterinary Science 31(7):396-399, 2011. e-Pub 2011.
      31. Tan JY, Valberg SJ, Sebastian MM, Davis GD, Kelly JR, Goehring LS, Harland MM, Kuebelbeck KL, Waldridge BM, Newton JC, Reimer JM. Suspected systemic calcinosis and calciphylaxis in 5 horses. Can Vet J 51(9):993-9, 2010. e-Pub 2010. PMID: 21119866.
      32. Inabnet WB, Milone L, Harris P, Durak E, Freeby MJ, Ahmed L, Sebastian MM, Lifante JC, Bessler M, Korner J. The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass. Surgery 147(2):303-9, 2010. e-Pub 2010. PMID: 19828168.
      33. Scherzer J, Sebastian M, Davis C, Ensley D, Hurley D. Clinical observation on differential effects of the trace elements selenium and copper during bovine embryo transfer. Bovine Practioner 43(2):160-7, 2009. e-Pub 2009.
      34. Bendon RW, Brendon RW, Sebastian MM. Stillborn infant with calcified chorionic epithelium, corneal scarring, and pericarditis. Fetal Pediatr Pathol 28(6):274-8, 2009. e-Pub 2009. PMID: 19842882.
      35. Sebastian, MM, Giles, RC, Donahu, JM, Sells, S, Fallon, L, Vickers, ML. Dermatophilus congolensis-associated placentitis, funisitis and abortion in a horse. Transboundary and Emerging Diseases 55(3-4):183-185, 2008. e-Pub 2008. PMID: 18405341.
      36. Sebastian, MM, Stewart, I, Williams, NM, Poonacha, KB, Sells, S, Vickers, ML, Harrison, L. Pathological, entomological, avian and meteorological investigation of a West nile virus epidemic in a horse farm. Transboundary and Emerging Diseases 55(2):134-139, 2008. e-Pub 2008. PMID: 18397501.
      37. Sebastian MM, Bernard W, Riddle T, Latimer C, Fitzgerald TD, Harrison LR. Mare Reproductive Loss Syndrome-A Review (Cover Page Review). Veterinary Pathology 45:710-22, 2008. e-Pub 2008.
      38. Sebastian, MM, Giles, RC, Roberts, J, Poonacha, KB, Harrison, L, Donahue, JM, Benirschke, K. Funisitis associated with leptospiral abortion in an equine placenta. Veterinary pathology 42(5):659-662, 2005. e-Pub 2005. PMID: 16145212.
      39. Bolin DC, Donahue JM, Vickers ML, Harrison L, Sells S, Giles RC, Hong CB, Poonacha KB, Roberts J, Sebastian MM, Swerczek TW, Tramontin R, Williams NM. Microbiologic and pathologic findings in an epidemic of equine pericarditis. J Vet Diagn Invest 17(1):38-44, 2005. e-Pub 2005. PMID: 15690949.
      40. Sebastian MM, Giles RC, Roberts JF, Poonacha KB, Donahue JM, Harrison LR, Benirschke K. Funisitis associated with leptospiral abortion in an equine placenta. Veterinary Pathology 42:659-62, 2005. e-Pub 2005.
      41. Flaminio JBF, Nydam DV, Sebastian M, Bernard WV, Tobin T, Hillegas JM, Matychak MB. The Mare Reproductive Loss Syndrome (MRLS) and the Eastern Tent Caterpillar: Immunological Testing of Aborting Mares. International Journal of Applied Research in Veterinary Medicine 3:207-16, 2005. e-Pub 2005.
      42. Bolin DC, Donahue JM, Vickers ML, Giles RC, Harrison L, Jackson C, Poonacha KB, Roberts JE, Sebastian MM, Sells SE, Tramontin R, Williams NM. Equine abortion and premature birth associated with Cellulosimicrobium cellulans infection. J Vet Diagn Invest 16(4):333-6, 2004. e-Pub 2004. PMID: 15305747.
      43. Sebastian MM, Giles RC. Fibrocartilaginous embolic myelopathy in a horse. Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine 51(7-8):341-343, 2004. e-Pub 2004. PMID: 15533115.
      44. Sebastian MM, Giles RC. Myelopathy associated with fibrocartilagenous emboli in a horse. Journal of Veterinary Medicine, Series 1 51:1-3, 2004. e-Pub 2004.
      45. Sebastian MM, Gantz M, Tobin T, Harkins J, Bosken J, Hughes C, Harrison L, Bernard WV, Richter D, Fitzgerald TD. The mare reproductive loss syndrome and the eastern Tent Caterpillar. Veterinary Therapeutics 4(4), 2003. e-Pub 2003. PMID: 15136975.
      46. Hughes C, Lehner F, Dirikolu L, Harkins D, Boyles J, McDowell K, Tobin T, Crutchfield J, Sebastian MM, Harrison L, Baskin SI. A simple and highly sensitive spectrophotometric method for the determination of cyanide in equine blood. Toxicology Mechanisms and Methods 13(2):129-138, 2003. e-Pub 2003. PMID: 20021191.
      47. Dirikolu L, Hughes C, Harkins D, Boyles J, Bosken J, Lehner F, Troppmann A, McDowell K, Tobin T, Sebastian MM, Harrison L, Crutchfield J, Baskin SI, Fitzgerald TD. The toxicokinetics of cyanide and mandelonitrile in the horse and their relevance to the mare reproductive loss syndrome. Toxicol Mech Methods 13(3):199-211, 2003. e-Pub 2003. PMID: 20021160.
      48. Roberts JF, Vickers ML, Sells SF, Watson DL, Billings SK, Jackson CB, Palmer-Ball BL, Harrison LR, Bolin DC, Giles RC, Sebastian MM. Passive surveillance of West Nile virus from wild birds of Kentucky. The Kentucky Warbler 79(2):53-9, 2003. e-Pub 2003.
      49. Sebastian MM, Anilkumar R, Mini M, Ismail PK, Rajan A. Reversal of aflatoxin induced liver damage by turmeric, curcumin and chitosan. International Journal of Animal Sciences 16:155-7, 2001. e-Pub 2001.
      50. Sebastian MM, Sreekumaran T, Madhusoodanan Pillai R, Ramachandran KM, Rajan A. Evaluation of antibodies as a diagnostic marker in ethmoid carcinoma. Journal of Veterinary and Animal Sciences 29:76-7, 1998. e-Pub 1998.
      51. Sebastian MM, Remani P, Rajan A. Jackfruit lectin as a histochemical marker for ethmoid carcinoma in bovines. International Journal of Animal Sciences 13:165-8, 1998. e-Pub 1998.
      52. Sebastian MM, Shanwaz KR, Eliyas A, Rajan A, Vasudevan DM. Demonstration of tumor associated antigen in ethmoid carcinoma. International Journal of Animal Sciences 13:117-20, 1998. e-Pub 1998.
      53. Valsala KV, Sebastian MM, Rajan A. Granulosa cell tumor in a civet cat (Viverricula indica). Indian Journal of Veterinary Pathology 19:51-2, 1995. e-Pub 1995.
      54. Sebastian MM, Mini M, Rajan A. Circulating immune complexes as a tumor marker in carcinoma of the ethmoid mucosa in cattle. Journal of Veterinary and Animal Sciences 26:37-9, 1995. e-Pub 1995.

      Invited Articles

      1. Sebastian MM, Bernard WV, Riddle TW, Latimer CR, Fitzgerald TD, Harrison LR. REVIEW paper: mare reproductive loss syndrome. Vet Pathol 45(5):710-22, 2008. e-Pub 2008. PMID: 18725479.

      Review Articles

      1. Sebastian, MM, Batra, H, Saini, ML, Kearney, S, Sherry, L, Alexanian, S, Cohen, M, Weber, W, Lennerz, J, Parwani, AV. Applications and challenges of utilizing digital pathology and AI-enabled workflows in clinical trials. Journal of Pathology Informatics 20, 2026. e-Pub 2026. PMID: 41631127.
      2. Zhao S, Habib SL, Senejani AG, Sebastian M, Kidane D. Role of Base Excision Repair in Innate Immune Cells and Its Relevance for Cancer Therapy. Biomedicines 10(3), 2022. e-Pub 2022. PMID: 35327359.
      3. Pantanowitz L, Bui MM, Chauhan C, ElGabry E, Hassell L, Li Z, Parwani AV, Salama ME, Sebastian M, Tulman D, Vepa S, Becich MJ. Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligence. Acad Pathol 9(1):100026, 2022. e-Pub 2022. PMID: 35669406.
      4. El Bairi, K, Haynes, HR, Blackley, EF, Fineberg, S, Shear, J, Turner, S, de Freitas, JR, Sur, D, Amendola, LC, Gharib, M, Kallala, A, Arun, I, Azmoudeh-Ardalan, F, Fujimoto, L, Sua, LF, Liu, SW, Lien, HC, Kirtani, P, Balancin, ML, El Attar, H, Guleria, P, Yang, W, Shash, E, Chen, IC, Bautista, V, Do Prado Moura, JF, Rapoport, B, Castaneda, CA, Spengler, E, Acosta-Haab, G, Frahm, I, Sanchez, J, Castillo, M, Bouchmaa, N, Md Zin, RR, Shui, R, Onyuma, T, Yang, W, Husain, Z, Willard-Gallo, K, Coosemans, A, Perez, EA, Provenzano, E, Ericsson, PG, Toi, M, Yang, W, Symmans, WF, Sebastian, MM, Yuan, Y, Lazar, A. The tale of TILs in breast cancer. npj Breast Cancer 7(1), 2021. e-Pub 2021. PMID: 34853355.
      5. Hudeček, J, Voorwerk, L, van Seijen, M, Nederlof, I, de Maaker, M, van den Berg, J, Van De Vijver, K, Sikorska, K, Adams, S, Demaria, S, Viale, G, Nielsen, TO, Badve, S, Michiels, S, Symmans, WF, Sotiriou, C, Rimm, DL, Hewitt, SM, Denkert, C, Loibl, S, Loi, S, Bartlett, JM, Pruneri, G, Dillon, D, Cheang, M, Tutt, A, Hall, JA, Kos, Z, Salgado, R, Kok, M, Horlings, HM, Hyytiäinen, A, Hida, AI, Thompson, A, Lefevre, A, Lazar, A, Gown, AM, Lo, A, Sapino, A, Madabhushi, A, Moreira, A, Richardson, AL, Vingiani, A, Beck, AH, Bellizzi, AM, Guerrero, A, Grigoriadis, A, Sebastian, MM, Yang, W, Yuan, Y. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. npj Breast Cancer 6(1), 2020. e-Pub 2020. PMID: 32436923.
      6. Amgad M, Stovgaard ES, Balslev E, Thagaard J, Chen W, Dudgeon S, Sharma A, Kerner JK, Denkert C, Yuan Y, AbdulJabbar K, Wienert S, Savas P, Voorwerk L, Beck AH, Madabhushi A, Hartman J, Sebastian M, Horlings HM, Hudecek J, Ciompi F, Moore DA, Singh R, Roblin E, Balancin ML, Mathieu MC, Lennerz JK, Kirtani P, Chen IC, Braybrooke JP, Pruneri G, Demaria S, Adams S, Schnitt SJ, Lakhani SR, Rojo F, Comerma L, Badve SS, Khojasteh M, Symmans WF, Sotiriou C, Gonzalez-Ericsson P, Pogue-Geile KL, Kim RS, Rimm DL, Viale G, Hewitt SM, Bartlett JMS, Penault-Llorca F, Goel S, Lien HC, Loibl S, Kos Z, Loi S, Hanna MG, Michiels S, Kok M, Nielsen TO, Lazar AJ, Bago-Horvath Z, Kooreman LFS, Laak JAWM VD, Saltz J, Gallas BD, Kurkure U, Barnes M, Salgado R, Cooper LAD, Working Group IIB. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer 6(1):16, 2020. e-Pub 2020. PMID: 32411818.

      Other Articles

      1. Brendon RW, Sebastian MM Erratum. Fetal and Pediatric Pathology 29(3):183, 2010.
      2. Sebastian M, Bernard W, Fitzgerald T Mare Reproductive Loss Syndrome (Review Article). Compendium on Continuing Education for the Practicing Veterinarian, 2006.

      Book Chapters

      1. Sebastian MM, Borjeson TM. Embryology and teratology, 863-890, 2019.
      2. Sebastian MM, Borjeson TM. In: Embryology and teratology. Elsevier, 28, 2019.
      3. Laflamme MA, Sebastian MM, Buetow BS. Cardiovascular, 135-153, 2012.
      4. Laflamme MA, Sebastian MM, Beutow BS. Chapter 10, Cardiovascular System. In: Comparative Anatomy & Histology: A Mouse and Human Atlas. Elsevier, 135-153, 2012.
      5. Sebastian MM. Mare reproductive loss syndrome, 1139-1144, 2011.
      6. Sebastian MM. Renal toxicity, 561-574, 2009.
      7. Sebastian M. Chapter 38, Renal Toxicity. In: Handbook of Toxicology of Chemical Warfare Agents. Academic Press, 561-574, 2009.
      8. Sebastian MM, Baskin SI, Czerwinski SE. Renal toxicity, 161-176, 2007.
      9. Sebastian MM, Bernard WV, Harrison L. Caterpillars and mare reproductive loss syndrome, 777-784, 2007.
      10. Baskin, SI, Czerwinski, SE, Anderson, JB, Sebastian, MM. Cardiovascular toxicity, 193-205, 2007.
      11. Sebastian MM. Role of pathology in diagnosis, 1100-1136, 2007.
      12. Sebastian, MM, Baskin, SI, Czerwinski, SE. Renal toxicity, 161-176, 2007.
      13. Sebastian MM, Bernard W. Chapter 63: Caterpillars and mare reproductive loss syndrome. In: Veterinary Toxicology: Basic & Clinical Principles. Academic Press, 777-784, 2007.
      14. Sebastian M. Chapter 91: Role of Pathology in Diagnosis. In: Veterinary Toxicology: Basic & Clinical Principles. Academic Press, 1100-1138, 2007.
      15. Perkins NR, Sebastian MM, Todhunter KH, Wylie RM, Begg AP, Gilkerson JR, Racklyeft DJ, Chicken C, Wilson MC, Cawdell-Smith AJ, Bryden WL. Chapter 26: Pregnancy loss in mares associated with exposure to caterpillars in Kentucky and Australia. In: Poisonous Plants: Global Research and Solutions. CABI Publishing, 165-169, 2007.
      16. Sebastian M, Czerwinski SE, Baskin SI. Chapter 13: Renal Toxicity. In: Veterinary Toxicology: Basic & Clinical Principles. Academic Press, 161-176, 2007.
      17. Baskin SI, Czerwinski SE, Anderson JB, Sebastian M. Chapter 16: Cardiovascular Toxicity. In: Veterinary Toxicology: Basic & Clinical Principles. Academic Press, 193-205, 2007.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top